Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.21 USD | +4.25% | +3.76% | -75.98% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 6.164 | 178.7 | 62.63 | 13.67 | 4.222 | - | - |
Enterprise Value (EV) 1 | 6.164 | 178.7 | 62.63 | 13.67 | 4.222 | 4.222 | 4.222 |
P/E ratio | -0.48 x | -8.14 x | -3.12 x | - | -0.38 x | -0.79 x | - |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - | - |
EV / EBITDA | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 482 | 1,076 | 1,195 | 1,486 | 1,910 | - | - |
Reference price 2 | 12.80 | 166.0 | 52.40 | 9.200 | 2.210 | 2.210 | 2.210 |
Announcement Date | 3/30/20 | 3/26/21 | 3/30/22 | 4/1/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | - | -17.96 | -19.58 | -23.83 | -31.08 | -24.21 | -26.01 | - |
Operating Margin | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | - | -19.6 | - | - | -24.21 | -26.01 | - |
Net income 1 | -10.65 | -17.94 | -19.6 | -23.74 | -30.86 | -24.21 | -32 | -40.24 |
Net margin | - | - | - | - | - | - | - | - |
EPS 2 | -26.40 | -20.40 | -16.80 | - | - | -5.770 | -2.780 | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/30/20 | 3/26/21 | 3/30/22 | 3/31/23 | 4/1/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | - | -5.676 | -5.723 | -5.175 | -6.111 | -6.822 | -5.987 | -6.053 | -6.053 | -6.053 | -6.053 | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -5.682 | -5.722 | - | - | - | - | -6.053 | -6.053 | -6.053 | -6.053 | - |
Net income 1 | -3.438 | -5.682 | -5.722 | -5.169 | -6.083 | -6.766 | -5.929 | -6.053 | -6.053 | -6.053 | -6.053 | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | - | -4.800 | -4.800 | - | - | - | - | -2.540 | -1.840 | -1.260 | -0.9600 | -0.8600 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/15/21 | 3/30/22 | 5/13/22 | 8/12/22 | 11/14/22 | 3/31/23 | 4/1/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | 2.34 | - | - | - | 0.02 | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 3/30/20 | 3/26/21 | 3/30/22 | 3/31/23 | 4/1/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.98% | 4.22M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- GNPX Stock
- Financials Genprex, Inc.